APO Research
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin Receptor Type 2

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Somatostatin Receptor Type 2 Industry Growth and Trends Forecast to 2032

19 December 202587 pages

Choose your research edition.

Industry ResearchSomatostatin Receptor Type 2 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin Receptor Type 2 Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Somatostatin Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin Receptor Type 2 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin Receptor Type 2 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Somatostatin Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Somatostatin Receptor Type 2 market include Amryt Pharma plc, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Ipsen SA, Progenics Pharmaceuticals Inc, Strongbridge Biopharma plc and Zucara Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Somatostatin Receptor Type 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Somatostatin Receptor Type 2 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Somatostatin Receptor Type 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Somatostatin Receptor Type 2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Somatostatin Receptor Type 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Somatostatin Receptor Type 2 Market by Company

Amryt Pharma plc

Crinetics Pharmaceuticals Inc

Daewoong Pharmaceutical Co Ltd

Ipsen SA

Progenics Pharmaceuticals Inc

Strongbridge Biopharma plc

Zucara Therapeutics Inc

Somatostatin Receptor Type 2 Segment by Type

CRN-00808

PRL-2903

Lanreotide Acetate

Others

Somatostatin Receptor Type 2 Segment by Application

Oncology

Hormonal Disorder

Metabolic Disorder

Others

Somatostatin Receptor Type 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin Receptor Type 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Somatostatin Receptor Type 2 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Somatostatin Receptor Type 2 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Somatostatin Receptor Type 2 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Somatostatin Receptor Type 2 Market Share by Region (2021-2026) Table 4. Global Somatostatin Receptor Type 2 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Somatostatin Receptor Type 2 Market Share by Region (2027-2032) Table 6. Global Somatostatin Receptor Type 2 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Somatostatin Receptor Type 2 Market Size Share by Type (2021-2026) Table 9. Global Somatostatin Receptor Type 2 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Somatostatin Receptor Type 2 Market Size Share Forecasted by Type (2027-2032) Table 11. North America Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Somatostatin Receptor Type 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Somatostatin Receptor Type 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Somatostatin Receptor Type 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Somatostatin Receptor Type 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Somatostatin Receptor Type 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Somatostatin Receptor Type 2 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Somatostatin Receptor Type 2 Market Size Share by Application (2021-2026) Table 24. Global Somatostatin Receptor Type 2 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Somatostatin Receptor Type 2 Market Size Share Forecasted by Application (2027-2032) Table 26. North America Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Somatostatin Receptor Type 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Somatostatin Receptor Type 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Somatostatin Receptor Type 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Somatostatin Receptor Type 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Somatostatin Receptor Type 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Somatostatin Receptor Type 2 Industry Trends Table 37. Somatostatin Receptor Type 2 Industry Drivers Table 38. Somatostatin Receptor Type 2 Industry Opportunities and Challenges Table 39. Somatostatin Receptor Type 2 Industry Restraints Table 40. Global Somatostatin Receptor Type 2 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Somatostatin Receptor Type 2 Revenue Market Share by Company (2021-2026) Table 42. Global Somatostatin Receptor Type 2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Somatostatin Receptor Type 2 Key Company Headquarters & Area Served Table 44. Global Somatostatin Receptor Type 2 Company, Product Type & Application Table 45. Global Somatostatin Receptor Type 2 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Somatostatin Receptor Type 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Amryt Pharma plc Company Information Table 49. Amryt Pharma plc Business Overview Table 50. Amryt Pharma plc Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Amryt Pharma plc Somatostatin Receptor Type 2 Product Portfolio Table 52. Amryt Pharma plc Recent Development Table 53. Crinetics Pharmaceuticals Inc Company Information Table 54. Crinetics Pharmaceuticals Inc Business Overview Table 55. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio Table 57. Crinetics Pharmaceuticals Inc Recent Development Table 58. Daewoong Pharmaceutical Co Ltd Company Information Table 59. Daewoong Pharmaceutical Co Ltd Business Overview Table 60. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product Portfolio Table 62. Daewoong Pharmaceutical Co Ltd Recent Development Table 63. Ipsen SA Company Information Table 64. Ipsen SA Business Overview Table 65. Ipsen SA Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Ipsen SA Somatostatin Receptor Type 2 Product Portfolio Table 67. Ipsen SA Recent Development Table 68. Progenics Pharmaceuticals Inc Company Information Table 69. Progenics Pharmaceuticals Inc Business Overview Table 70. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio Table 72. Progenics Pharmaceuticals Inc Recent Development Table 73. Strongbridge Biopharma plc Company Information Table 74. Strongbridge Biopharma plc Business Overview Table 75. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product Portfolio Table 77. Strongbridge Biopharma plc Recent Development Table 78. Zucara Therapeutics Inc Company Information Table 79. Zucara Therapeutics Inc Business Overview Table 80. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product Portfolio Table 82. Zucara Therapeutics Inc Recent Development Table 83. North America Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. North America Somatostatin Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 85. North America Somatostatin Receptor Type 2 Market Share by Country (2021-2026) Table 86. North America Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. North America Somatostatin Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 88. Europe Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Europe Somatostatin Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 90. Europe Somatostatin Receptor Type 2 Market Share by Country (2021-2026) Table 91. Europe Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Europe Somatostatin Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 93. Asia-Pacific Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 95. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Country (2021-2026) Table 96. Asia-Pacific Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Asia-Pacific Somatostatin Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 98. Latin America Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Latin America Somatostatin Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 100. Latin America Somatostatin Receptor Type 2 Market Share by Country (2021-2026) Table 101. Latin America Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Latin America Somatostatin Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 103. Middle East & Africa Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 105. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2021-2026) Table 106. Middle East & Africa Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Middle East & Africa Somatostatin Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Somatostatin Receptor Type 2 Product Image Figure 3. Global Somatostatin Receptor Type 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 5. Global Somatostatin Receptor Type 2 Market Share by Region: 2025 VS 2032 Figure 6. Global Somatostatin Receptor Type 2 Market Share by Region (2021-2032) Figure 7. North America Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CRN-00808 Image Figure 13. Global CRN-00808 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. PRL-2903 Image Figure 15. Global PRL-2903 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Lanreotide Acetate Image Figure 17. Global Lanreotide Acetate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Somatostatin Receptor Type 2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Somatostatin Receptor Type 2 Market Share by Type 2025 VS 2032 Figure 22. North America Somatostatin Receptor Type 2 Market Size Share by Type (2021-2032) Figure 23. Europe Somatostatin Receptor Type 2 Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Somatostatin Receptor Type 2 Market Size Share by Type (2021-2032) Figure 25. Latin America Somatostatin Receptor Type 2 Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Somatostatin Receptor Type 2 Market Size Share by Type (2021-2032) Figure 27. Oncology Image Figure 28. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hormonal Disorder Image Figure 30. Global Hormonal Disorder Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Metabolic Disorder Image Figure 32. Global Metabolic Disorder Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Somatostatin Receptor Type 2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Somatostatin Receptor Type 2 Market Share by Application 2025 VS 2032 Figure 37. North America Somatostatin Receptor Type 2 Market Size Share by Application (2021-2032) Figure 38. Europe Somatostatin Receptor Type 2 Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Somatostatin Receptor Type 2 Market Size Share by Application (2021-2032) Figure 40. Latin America Somatostatin Receptor Type 2 Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Somatostatin Receptor Type 2 Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Somatostatin Receptor Type 2 Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Somatostatin Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Somatostatin Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 47. Europe Somatostatin Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Somatostatin Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 50. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 53. Latin America Somatostatin Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Somatostatin Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 56. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • CRN-00808
  • PRL-2903
  • Lanreotide Acetate
  • Others
Applications
  • Oncology
  • Hormonal Disorder
  • Metabolic Disorder
  • Others
Companies covered
  • Amryt Pharma plc
  • Crinetics Pharmaceuticals Inc
  • Daewoong Pharmaceutical Co Ltd
  • Ipsen SA
  • Progenics Pharmaceuticals Inc
  • Strongbridge Biopharma plc
  • Zucara Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Somatostatin Receptor Type 2 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Somatostatin Receptor Type 2 Market Size by Region (2021-2032)
  5. 1.4.1 Global Somatostatin Receptor Type 2 Market Size by Region (2021-2026)
  6. 1.4.2 Global Somatostatin Receptor Type 2 Market Size by Region (2027-2032)
  7. 1.5 Key Regions Somatostatin Receptor Type 2 Market Size (2021-2032)
  8. 1.5.1 North America Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Somatostatin Receptor Type 2 Market Size Growth Rate (2021-2032)
2 Somatostatin Receptor Type 2 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CRN-00808
  3. 2.1.2 PRL-2903
  4. 2.1.3 Lanreotide Acetate
  5. 2.1.4 Others
  6. 2.2 Global Somatostatin Receptor Type 2 Market Size by Type
  7. 2.2.1 Global Somatostatin Receptor Type 2 Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Somatostatin Receptor Type 2 Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Somatostatin Receptor Type 2 Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Somatostatin Receptor Type 2 Market Size by Regions
  11. 2.3.1 North America Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Somatostatin Receptor Type 2 Market Size Breakdown by Type (2021-2026)
3 Somatostatin Receptor Type 2 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Oncology
  3. 3.1.2 Hormonal Disorder
  4. 3.1.3 Metabolic Disorder
  5. 3.1.4 Others
  6. 3.2 Global Somatostatin Receptor Type 2 Market Size by Application
  7. 3.2.1 Global Somatostatin Receptor Type 2 Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Somatostatin Receptor Type 2 Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Somatostatin Receptor Type 2 Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Somatostatin Receptor Type 2 Market Size by Regions
  11. 3.3.1 North America Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Somatostatin Receptor Type 2 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Somatostatin Receptor Type 2 Industry Trends
  2. 4.2 Somatostatin Receptor Type 2 Industry Drivers
  3. 4.3 Somatostatin Receptor Type 2 Industry Opportunities and Challenges
  4. 4.4 Somatostatin Receptor Type 2 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Somatostatin Receptor Type 2 Revenue (2021-2026)
  2. 5.2 Global Somatostatin Receptor Type 2 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Somatostatin Receptor Type 2 Key Company Headquarters & Area Served
  4. 5.4 Global Somatostatin Receptor Type 2 Company, Product Type & Application
  5. 5.5 Global Somatostatin Receptor Type 2 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Somatostatin Receptor Type 2 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Somatostatin Receptor Type 2 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Somatostatin Receptor Type 2 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Amryt Pharma plc
  2. 6.1.1 Amryt Pharma plc Company Information
  3. 6.1.2 Amryt Pharma plc Business Overview
  4. 6.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Product Portfolio
  6. 6.1.5 Amryt Pharma plc Recent Developments
  7. 6.2 Crinetics Pharmaceuticals Inc
  8. 6.2.1 Crinetics Pharmaceuticals Inc Company Information
  9. 6.2.2 Crinetics Pharmaceuticals Inc Business Overview
  10. 6.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio
  12. 6.2.5 Crinetics Pharmaceuticals Inc Recent Developments
  13. 6.3 Daewoong Pharmaceutical Co Ltd
  14. 6.3.1 Daewoong Pharmaceutical Co Ltd Company Information
  15. 6.3.2 Daewoong Pharmaceutical Co Ltd Business Overview
  16. 6.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product Portfolio
  18. 6.3.5 Daewoong Pharmaceutical Co Ltd Recent Developments
  19. 6.4 Ipsen SA
  20. 6.4.1 Ipsen SA Company Information
  21. 6.4.2 Ipsen SA Business Overview
  22. 6.4.3 Ipsen SA Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Ipsen SA Somatostatin Receptor Type 2 Product Portfolio
  24. 6.4.5 Ipsen SA Recent Developments
  25. 6.5 Progenics Pharmaceuticals Inc
  26. 6.5.1 Progenics Pharmaceuticals Inc Company Information
  27. 6.5.2 Progenics Pharmaceuticals Inc Business Overview
  28. 6.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio
  30. 6.5.5 Progenics Pharmaceuticals Inc Recent Developments
  31. 6.6 Strongbridge Biopharma plc
  32. 6.6.1 Strongbridge Biopharma plc Company Information
  33. 6.6.2 Strongbridge Biopharma plc Business Overview
  34. 6.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product Portfolio
  36. 6.6.5 Strongbridge Biopharma plc Recent Developments
  37. 6.7 Zucara Therapeutics Inc
  38. 6.7.1 Zucara Therapeutics Inc Company Information
  39. 6.7.2 Zucara Therapeutics Inc Business Overview
  40. 6.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product Portfolio
  42. 6.7.5 Zucara Therapeutics Inc Recent Developments
7 North America
  1. 7.1 North America Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  3. 7.3 North America Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  3. 8.3 Europe Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  3. 10.3 South America Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst